| Inflammation and depression: a causal or coincidental link to the pathophysiology? |
46 |
| Gut-brain actions underlying comorbid anxiety and depression associated with inflammatory bowel disease |
22 |
| A brief history of antidepressant drug development: from tricyclics to beyond ketamine |
13 |
| A five-year follow-up study of antioxidants, oxidative stress and polyunsaturated fatty acids in schizophrenia |
10 |
| Gene-environment interactions between HPA-axis genes and stressful life events in depression: a systematic review |
8 |
| Structural-functional brain changes in depressed patients during and after electroconvulsive therapy |
7 |
| Reduced grey matter volume in frontal and temporal areas in depression: contributions from voxel-based morphometry study |
7 |
| Cannabinoid signalling in embryonic and adult neurogenesis: possible implications for psychiatric and neurological disorders |
6 |
| Anaesthesia for electroconvulsive therapy - new tricks for old drugs: a systematic review |
5 |
| ECT in schizophrenia: a review of the evidence |
5 |
| Psilocybin lacks antidepressant-like effect in the Flinders Sensitive Line rat |
5 |
| Quality of life among parents of South African children with autism spectrum disorder |
4 |
| Distinctive neuropsychological profiles differentiate patients with functional memory disorder from patients with amnestic-mild cognitive impairment |
4 |
| A randomised controlled trial of the monoaminergic stabiliser (-)-OSU6162 in treatment of myalgic encephalomyelitis/chronic fatigue syndrome |
4 |
| Magnetic resonance (MR) spectroscopic measurement of gamma-aminobutyric acid (GABA) in major depression before and after electroconvulsive therapy |
4 |
| Individual responses of rodents in modelling of affective disorders and in their treatment: prospective review |
4 |
| Mediator effects of parameters of inflammation and neurogenesis from a N-acetyl cysteine clinical-trial for bipolar depression |
4 |
| Effects of erythropoietin on body composition and fat-glucose metabolism in patients with affective disorders |
4 |
| Effects of prenatal alcohol exposure on language, speech and communication outcomes: a review longitudinal studies |
3 |
| CGRP in a gene-environment interaction model for depression: effects of antidepressant treatment |
3 |
| Bipolar disorder patients display reduced serum complement levels and elevated peripheral blood complement expression levels |
3 |
| Reliable and efficient recording of the error-related negativity with a speeded Eriksen Flanker Task |
3 |
| The effects of cannabis use on salience attribution: a systematic review |
3 |
| Vascular risk factors and the relationships between cognitive impairment and hypoperfusion in late-onset Alzheimer's disease |
3 |
| Clinically relevant and simple immune system measure is related to symptom burden in bipolar disorder |
3 |
| Associations between C-reactive protein levels and cognition during the first 6 months after acute psychosis |
3 |
| A randomised, placebo-controlled 24-week study evaluating adjunctive brexpiprazole in patients with major depressive disorder |
3 |
| Bipolar disorder and the endocannabinoid system |
3 |
| Cognitive and affective theory of mind in Korsakoff's syndrome |
3 |
| Neurological soft signs significantly differentiate schizophrenia patients from healthy controls |
3 |
| Gene polymorphisms and response to transcranial direct current stimulation for auditory verbal hallucinations in schizophrenia |
2 |
| The menstrual cycle may not be limited to the endometrium but also may impact gut permeability |
2 |
| A clinimetric analysis of a BPRS-6 scale for schizophrenia severity |
2 |
| Auditory brainstem response (ABR) profiling tests as diagnostic support for schizophrenia and adult attention-deficit hyperactivity disorder (ADHD) |
2 |
| Obsessive-compulsive symptoms in schizophrenia: a review |
2 |
| Regional differences in dendritic spine density confer resilience to chronic social defeat stress |
2 |
| Prelimbic neuronal nitric oxide synthase inhibition exerts antidepressant-like effects independently of BDNF signalling cascades |
2 |
| Circuits regulating pleasure and happiness: evolution and role in mental disorders |
2 |
| Observer-rated retardation but not agitation corresponds to objective motor measures in depression |
1 |
| Efficacy of intervention at traffic schools reducing impulsive action, and association with candidate gene variants |
1 |
| A new way of rapidly screening for depression in multiple sclerosis using Emotional Thermometers |
1 |
| Neuropeptide Y and religious commitment in healthy young women |
1 |
| Relapse of drunk driving and association with traffic accidents, alcohol-related problems and biomarkers of impulsivity |
1 |
| A comprehensive study of oxidative stress in patients with somatic symptom disorder |
1 |
| Markers of HPA-axis activity and nucleic acid damage from oxidation after electroconvulsive stimulations in rats |
1 |
| The efficacy of group cognitive-behavioural therapy plus duloxetine for generalised anxiety disorder versus duloxetine alone |
1 |
| The Food Addiction Denmark (FADK) Project: a combined survey and register-based study |
1 |
| A comparison of immersive virtual reality with traditional neuropsychological measures in the assessment of executive functions |
1 |
| Efficacy of ethyl-EPA as a treatment for Huntington disease: a systematic review and meta-analysis |
1 |
| Clinical validation of the Psychotic Depression Assessment Scale (PDAS) against independent global severity ratings in older adults |
1 |
